Continuing research to pursue identification of other strategies that meet the above criteria will permit Advantagene continued growth and impact in the fight against cancer. Advantagene is concurrently working on the development of advanced technologies through sponsored and collaborative efforts with leading academic researchers and strategic partnerships with complementing industry groups.  Advantagene has developed and continually seeks to develop strategic partnerships with complementing groups for the use of intellectual property, products, or services. Advantagene has already collaborated with and received support from:  The Methodist Hospital and Baylor College of Medicine, Houston, Texas; GlaxoSmithKline, Research Triangle Park, North Carolina; Massachusetts General Hospital, Harvard Medical School, Boston; Universidad Autonoma de Nuevo Leon, Mexico;  and others.